Zhilei Cui

745 total citations
27 papers, 387 citations indexed

About

Zhilei Cui is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhilei Cui has authored 27 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhilei Cui's work include MicroRNA in disease regulation (3 papers), Mesenchymal stem cell research (3 papers) and Phagocytosis and Immune Regulation (3 papers). Zhilei Cui is often cited by papers focused on MicroRNA in disease regulation (3 papers), Mesenchymal stem cell research (3 papers) and Phagocytosis and Immune Regulation (3 papers). Zhilei Cui collaborates with scholars based in China, Pakistan and United States. Zhilei Cui's co-authors include Lin Song, Weiguo Xu, Xuejun Guo, Xiaojun Guan, Xi Chen, Fengfeng Han, Xuejun Guo, Linlin Zhang, Shulin Zhang and Guorui Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Life Sciences.

In The Last Decade

Zhilei Cui

26 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhilei Cui China 12 143 128 80 72 65 27 387
Zhaoguo Li China 10 168 1.2× 150 1.2× 41 0.5× 44 0.6× 70 1.1× 20 376
Lehe Yang China 11 157 1.1× 95 0.7× 17 0.2× 27 0.4× 41 0.6× 21 305
Richard Coffey United States 8 116 0.8× 114 0.9× 252 3.1× 73 1.0× 44 0.7× 12 657
Xinwei Wang China 12 160 1.1× 71 0.6× 21 0.3× 67 0.9× 75 1.2× 21 503
Thomas Scambler United Kingdom 10 205 1.4× 172 1.3× 25 0.3× 175 2.4× 38 0.6× 11 483
Mateusz Sobczak Poland 6 212 1.5× 59 0.5× 21 0.3× 27 0.4× 104 1.6× 7 405
Péter Árkosy Hungary 9 285 2.0× 52 0.4× 21 0.3× 25 0.3× 51 0.8× 32 440
Qing Mao China 13 143 1.0× 24 0.2× 67 0.8× 49 0.7× 37 0.6× 27 339
Elisabeth Feifel Austria 13 289 2.0× 90 0.7× 18 0.2× 61 0.8× 31 0.5× 22 485

Countries citing papers authored by Zhilei Cui

Since Specialization
Citations

This map shows the geographic impact of Zhilei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhilei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhilei Cui more than expected).

Fields of papers citing papers by Zhilei Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhilei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhilei Cui. The network helps show where Zhilei Cui may publish in the future.

Co-authorship network of co-authors of Zhilei Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Zhilei Cui. A scholar is included among the top collaborators of Zhilei Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhilei Cui. Zhilei Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xinyi, Zhilei Cui, Xiao Yuan, et al.. (2025). Nanomaterial-Based Autophagy Modulation: Multiple Weapons to Inflame Immune Systems and the Tumor Microenvironment. Biomaterials Research. 29. 111–111. 1 indexed citations
2.
Huang, Shuo, Miaomiao Xu, Chao Li, et al.. (2025). Efficient delivery of anlotinib and radioiodine by long circulating nano-capsules for active enhanced suppression of anaplastic thyroid carcinoma. Journal of Nanobiotechnology. 23(1). 180–180. 2 indexed citations
3.
4.
Feng, Hao, Z. Y. Ren, Xiang Li, et al.. (2023). SNHG3/WISP2 Axis Promotes Hela Cell Migration and InvasionviaActivating Wnt/β-Catenin Signaling. Cancer Genomics & Proteomics. 20(6suppl). 744–753. 2 indexed citations
5.
Cui, Zhilei, Rongrong Ren, Wenjing Ye, et al.. (2023). Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages. International Immunopharmacology. 122. 110652–110652. 15 indexed citations
6.
Dong, Wen‐Wen, et al.. (2023). Laser speckle contrast imaging to monitor microcirculation: An effective method to predict outcome in patients with sepsis and septic shock. Frontiers in Bioengineering and Biotechnology. 10. 1067739–1067739. 4 indexed citations
7.
Cui, Zhilei, Linlin Zhang, & Lin Song. (2022). Differences of inflammatory microenvironment and sensitive correlation to cisplatin-chemotherapy in lung adenocarcinoma and squamous cell carcinoma. SHILAP Revista de lepidopterología. 3(4). e151–e151. 5 indexed citations
8.
Wang, Shilei, Ying Chen, Jie Tang, et al.. (2021). The Cytotoxic Molecule Ansamitocin P-3 Suppresses Cell Proliferation and Tumor Growth in Lung Carcinoma. ICUS and Nursing Web Journal. 1 indexed citations
9.
Khan, Muhammad Tahir, Sajid Ali, Anwar Sheed Khan, et al.. (2021). Insight into the drug resistance whole genome of Mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan. Infection Genetics and Evolution. 92. 104861–104861. 8 indexed citations
10.
Cui, Zhilei, Lin Song, Wenjing Ye, et al.. (2021). CD47 blockade enhances therapeutic efficacy of cisplatin against lung carcinoma in a murine model. Experimental Cell Research. 405(2). 112677–112677. 11 indexed citations
11.
Khan, Muhammad Tahir, Sathishkumar Chinnasamy, Zhilei Cui, Muhammad Irfan, & Dong‐Qing Wei. (2020). Mechanistic analysis of A46V, H57Y, and D129N in pyrazinamidase associated with pyrazinamide resistance. Saudi Journal of Biological Sciences. 27(11). 3150–3156. 4 indexed citations
12.
Khan, Muhammad Tahir, Abrar Ahmed, Arif Ali, et al.. (2020). SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study. Archives of Microbiology. 203(1). 59–66. 35 indexed citations
13.
Zhang, Guorui, Xiaoming Li, Haiyang Yu, et al.. (2019). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced aryl hydrocarbon receptor activation enhanced the suppressive function of mesenchymal stem cells against splenocyte proliferation. In Vitro Cellular & Developmental Biology - Animal. 55(8). 633–640. 4 indexed citations
14.
Cui, Zhilei, Zhen Liu, Shulin Zhang, et al.. (2019). TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells. Life Sciences. 224. 23–32. 17 indexed citations
15.
16.
17.
Song, Lin, Xiaojun Guan, Xi Chen, et al.. (2014). Mesenchymal Stem Cells Reduce Cigarette Smoke-Induced Inflammation and Airflow Obstruction in Rats via TGF-β1 Signaling. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(5). 582–590. 21 indexed citations
18.
Peng, Xiaohua, Zhilei Cui, Wen Gu, Weiguo Xu, & Xuejun Guo. (2014). Low level of LAT–PLC-γ1 interaction is associated with Th2 polarized differentiation: A contributing factor to the etiology of asthma. Cellular Immunology. 290(1). 131–137. 5 indexed citations
19.
Guan, Xiaojun, Lin Song, Fengfeng Han, et al.. (2012). Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptors. Journal of Cellular Biochemistry. 114(2). 323–335. 102 indexed citations
20.
Cui, Zhilei, et al.. (2009). [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].. PubMed. 89(5). 347–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaoguo Li Breakdown of academic impact, for papers by Lehe Yang Breakdown of academic impact, for papers by Richard Coffey Breakdown of academic impact, for papers by Xinwei Wang Breakdown of academic impact, for papers by Thomas Scambler Breakdown of academic impact, for papers by Mateusz Sobczak Breakdown of academic impact, for papers by Péter Árkosy Breakdown of academic impact, for papers by Qing Mao Breakdown of academic impact, for papers by Elisabeth Feifel
Rankless by CCL
2026